SEC Form 4 · accession 0001607969-26-000002
Varex Imaging Corp · VREX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shubham Maheshwari
Officer — Chief Financial Officer
Period of report
Sep 11, 2026
Accepted (ET)
Sep 15, 2026 · 5:44 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001681622
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 11, 2026 | M | 160,944 | $13.61 | A | 269,972 | D | |
| Common StockF2,F3 | Sep 11, 2026 | S | 130,000 | $18.462 | D | 139,972 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F4 | $13.61 | Sep 11, 2026 | M | 160,944 | D | — | Aug 15, 2030 | Common Stock | 160,944 | 0 | D |
Explanation of responses
- F1Includes 2,137 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan since the last Form 4 filing of the reporting person.
- F2The sales reported on this Form 4 were effected pursuant to a broker-assisted sell-to-cover exercise of fully vested options. The shares were sold solely to cover the aggregate exercise price, applicable tax withholdings and broker's fees. The reporting person retained all remaining shares acquired upon exercise.
- F3The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.460 to $18.470. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- F4These Performance Stock Options were subject to a four-year vesting schedule. 25% of the total number of options vested on August 15, 2021 and the remaining options vested monthly thereafter on a pro rata basis.